Variant report

Variant	esv1792520
Chromosome Location	chr4:69521311-69592846
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:457)
CpG islands
(count:306)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:457 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:69521827-69522720	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:69524230-69524826	HepG2	liver:	n/a	n/a
3	ATF1	chr4:69559343-69559671	K562	blood:	n/a	n/a
4	BATF	chr4:69522977-69523278	GM12878	blood:	n/a	n/a
5	BATF	chr4:69523003-69523215	GM12878	blood:	n/a	n/a
6	BATF	chr4:69538989-69539205	GM12878	blood:	n/a	n/a
7	BCL11A	chr4:69523069-69523272	GM12878	blood:	n/a	n/a
8	BCL3	chr4:69536262-69536632	A549	lung:	n/a	n/a
9	BHLHE40	chr4:69522248-69522562	GM12878	blood:	n/a	n/a
10	BHLHE40	chr4:69559209-69559522	K562	blood:	n/a	n/a
11	BHLHE40	chr4:69583763-69584005	GM12878	blood:	n/a	n/a
12	CEBPB	chr4:69574454-69574539	H1-hESC	embryonic stem cell:	n/a	chr4:69574511-69574522
13	CEBPB	chr4:69536277-69536474	HepG2	liver:	n/a	chr4:69536341-69536354
14	CEBPB	chr4:69536204-69536567	A549	lung:	n/a	chr4:69536341-69536354
15	CEBPB	chr4:69578074-69578242	A549	lung:	n/a	n/a
16	CEBPB	chr4:69536174-69536504	A549	lung:	n/a	chr4:69536341-69536354
17	CEBPB	chr4:69536198-69536502	MCF-7	breast:	n/a	chr4:69536341-69536354
18	CEBPB	chr4:69574389-69574642	A549	lung:	n/a	chr4:69574511-69574522
19	CEBPB	chr4:69574361-69574618	HepG2	liver:	n/a	chr4:69574511-69574522
20	CEBPB	chr4:69530297-69530431	A549	lung:	n/a	chr4:69530340-69530351
21	CEBPB	chr4:69530299-69530470	HepG2	liver:	n/a	chr4:69530340-69530351
22	CEBPB	chr4:69568931-69569294	H1-hESC	embryonic stem cell:	n/a	n/a
23	CEBPB	chr4:69580237-69580432	H1-hESC	embryonic stem cell:	n/a	n/a
24	CHD1	chr4:69583916-69583936	GM12878	blood:	n/a	n/a
25	CTCF	chr4:69538940-69539090	K562	blood:	n/a	n/a
26	CTCF	chr4:69538977-69539097	ProgFib	skin:	n/a	n/a
27	CTCF	chr4:69537020-69537170	HEEpiC	esophagus:	n/a	n/a
28	CTCF	chr4:69539026-69539117	GM13977	blood:	n/a	n/a
29	CTCF	chr4:69548640-69548790	HepG2	liver:	n/a	n/a
30	CTCF	chr4:69537760-69537910	GM12873	blood:	n/a	n/a
31	CTCF	chr4:69537020-69537170	GM12868	blood:	n/a	n/a
32	CTCF	chr4:69523050-69523257	GM13977	blood:	n/a	n/a
33	CTCF	chr4:69523075-69523227	GM12878	blood:	n/a	n/a
34	CTCF	chr4:69538988-69539100	GM12892	blood:	n/a	n/a
35	CTCF	chr4:69539840-69539990	GM12871	blood:	n/a	n/a
36	CTCF	chr4:69537009-69537226	H1-hESC	embryonic stem cell:	n/a	n/a
37	CTCF	chr4:69538999-69539085	MCF-7	breast:	n/a	n/a
38	CTCF	chr4:69539000-69539150	SK-N-SH_RA	brain:	n/a	n/a
39	CTCF	chr4:69539020-69539170	NHEK	skin:	n/a	n/a
40	CTCF	chr4:69537116-69537164	GM12878	blood:	n/a	n/a
41	CTCF	chr4:69537000-69537150	GM12873	blood:	n/a	n/a
42	CTCF	chr4:69537020-69537170	SAEC	small airway:	n/a	n/a
43	CTCF	chr4:69538980-69539130	GM12872	blood:	n/a	n/a
44	CTCF	chr4:69523069-69523238	HepG2	liver:	n/a	n/a
45	CTCF	chr4:69537022-69537277	NHEK	skin:	n/a	n/a
46	CTCF	chr4:69538974-69539100	Hela-S3	cervix:	n/a	n/a
47	CTCF	chr4:69539830-69539885	GM19240	blood:	n/a	n/a
48	CTCF	chr4:69537752-69537837	LNCaP	prostate:	n/a	n/a
49	CTCF	chr4:69537300-69537450	HEEpiC	esophagus:	n/a	n/a
50	CTCF	chr4:69537040-69537190	GM12869	blood:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:69522639-69522689	HIPEpiC	eye:	n/a
2	chr4:69522639-69522689	HIPEpiC	eye:	n/a
3	chr4:69536319-69536369	NHBE	bronchial:	n/a
4	chr4:69522639-69522689	ProgFib	skin:	n/a
5	chr4:69522639-69522689	HRPEpiC	eye:	n/a
6	chr4:69537826-69537876	PANC-1	pancreas:	n/a
7	chr4:69537826-69537876	AG10803	skin:	n/a
8	chr4:69537806-69537856	NHBE	bronchial:	n/a
9	chr4:69537826-69537876	HCPEpiC	choroid plexus:	n/a
10	chr4:69536319-69536369	NH-A	brain:	n/a
11	chr4:69537806-69537856	AG09309	skin:	n/a
12	chr4:69537589-69537639	HPAEpiC	pulmonary alveolar:	n/a
13	chr4:69537826-69537876	Hepatocyte	liver:	n/a
14	chr4:69536319-69536369	K562	blood:	n/a
15	chr4:69537826-69537876	HMEC	breast:	n/a
16	chr4:69537806-69537856	PFSK-1	brain:	n/a
17	chr4:69537806-69537856	HEEpiC	esophagus:	n/a
18	chr4:69537806-69537856	Hepatocyte	liver:	n/a
19	chr4:69537589-69537639	HUVEC	blood vessel:	n/a
20	chr4:69536319-69536369	ECC-1	luminal epithelium:	n/a
21	chr4:69522639-69522689	HEEpiC	esophagus:	n/a
22	chr4:69537826-69537876	HCM	heart:	n/a
23	chr4:69537826-69537876	A549	lung:	n/a
24	chr4:69536319-69536369	AG09309	skin:	n/a
25	chr4:69522639-69522689	NH-A	brain:	n/a
26	chr4:69537589-69537639	MCF-7	breast:	n/a
27	chr4:69537589-69537639	PFSK-1	brain:	n/a
28	chr4:69522639-69522689	HRCEpiC	kidney:	n/a
29	chr4:69536319-69536369	AG04450	lung:	fetal
30	chr4:69537826-69537876	ECC-1	luminal epithelium:	n/a
31	chr4:69537826-69537876	GM19239	blood:	n/a
32	chr4:69537806-69537856	IMR90	lung:	fetal
33	chr4:69536319-69536369	HCPEpiC	choroid plexus:	n/a
34	chr4:69522639-69522689	Hela-S3	cervix:	n/a
35	chr4:69537806-69537856	HUVEC	blood vessel:	n/a
36	chr4:69522639-69522689	BE2_C	brain:	n/a
37	chr4:69537826-69537876	CMK	blood:	n/a
38	chr4:69537589-69537639	H1-hESC	embryonic stem cell:	embryo
39	chr4:69537806-69537856	GM12878	blood:	n/a
40	chr4:69536319-69536369	HCF	heart:	n/a
41	chr4:69536319-69536369	Hela-S3	cervix:	n/a
42	chr4:69537806-69537856	LNCaP	prostate:	n/a
43	chr4:69522639-69522689	PFSK-1	brain:	n/a
44	chr4:69537826-69537876	RPTEC	kidney:	n/a
45	chr4:69536319-69536369	Caco-2	colon:	n/a
46	chr4:69537589-69537639	SAEC	small airway:	n/a
47	chr4:69522639-69522689	HCPEpiC	choroid plexus:	n/a
48	chr4:69536319-69536369	Jurkat	blood:	n/a
49	chr4:69522639-69522689	GM06990	blood:	n/a
50	chr4:69522639-69522689	Caco-2	colon:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:68794213..68794935-chr4:69590279..69590859,2	MCF-7	breast:
2	chr3:73105975..73106777-chr4:69561197..69562068,2	MCF-7	breast:
3	chr4:69590462..69592610-chr4:69729563..69731579,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000248635	TF binding region
UGT2B15	TF binding region
ENSG00000248635	CpG island
UGT2B15	CpG island

Extended variants
information (count: 1614 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:1614 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564401896	chr4:69521368-69521369	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs533305659	chr4:69521383-69521384	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs528497847	chr4:69521401-69521402	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs75435625	chr4:69521410-69521411	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs371733886	chr4:69521431-69521432	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs142386269	chr4:69521459-69521460	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs375634448	chr4:69521467-69521468	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs528916401	chr4:69521495-69521496	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs185969558	chr4:69521525-69521526	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs568892068	chr4:69521599-69521600	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs189261926	chr4:69521600-69521601	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs531552414	chr4:69521615-69521616	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs550936670	chr4:69521675-69521676	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs571036403	chr4:69521796-69521797	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs182558960	chr4:69521936-69521937	Enhancers Genic enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs553274220	chr4:69522004-69522005	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs35529523	chr4:69522005-69522006	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs559807181	chr4:69522025-69522026	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs535492111	chr4:69522026-69522027	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs555808378	chr4:69522027-69522028	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs575694642	chr4:69522037-69522038	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs544386467	chr4:69522077-69522078	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs140856261	chr4:69522091-69522092	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs374961375	chr4:69522109-69522110	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs147929412	chr4:69522110-69522111	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs372552314	chr4:69522125-69522126	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs577912880	chr4:69522149-69522150	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs540502921	chr4:69522168-69522169	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs560469059	chr4:69522214-69522215	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs528876505	chr4:69522265-69522266	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs542306988	chr4:69522276-69522277	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs144609922	chr4:69522336-69522337	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs185931332	chr4:69522393-69522394	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs191029526	chr4:69522424-69522425	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs570929558	chr4:69522455-69522456	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs533365212	chr4:69522472-69522473	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs546876002	chr4:69522473-69522474	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs568467489	chr4:69522545-69522546	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs566852453	chr4:69522585-69522586	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs182801208	chr4:69522601-69522602	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs369546461	chr4:69522624-69522625	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs549148998	chr4:69522625-69522626	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs569243371	chr4:69522639-69522640	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs537906012	chr4:69522640-69522641	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs374237116	chr4:69522654-69522655	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs377460253	chr4:69522697-69522698	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs202229066	chr4:69522718-69522719	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs368113447	chr4:69522724-69522725	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs185754674	chr4:69522780-69522781	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs534009404	chr4:69522807-69522808	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Graft versus host disease	20877625	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Osteoporosis	20877625	CNVD
Osteoporosis	19737800	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Glioblastoma multiforme	21138945	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Oral cancer	21386901	CNVD
Alcoholism	21790672	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	20967226	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:143 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:69513000-69522800	Weak transcription	Pancreas	Pancrea
2	chr4:69516600-69521800	Strong transcription	Liver	Liver
3	chr4:69519800-69522200	Enhancers	NHEK	skin
4	chr4:69519800-69523000	Enhancers	HMEC	breast
5	chr4:69520400-69521800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr4:69520400-69523000	Enhancers	Breast Myoepithelial Primary Cells	Breast
7	chr4:69520400-69523000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr4:69520800-69521800	Enhancers	A549	lung
9	chr4:69520800-69521800	Enhancers	HepG2	liver
10	chr4:69521000-69522600	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr4:69521200-69521600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
12	chr4:69521200-69522600	Enhancers	Rectal Mucosa Donor 31	rectum
13	chr4:69521200-69522600	Enhancers	Stomach Mucosa	stomach
14	chr4:69521200-69522800	Enhancers	H9 Cell Line	embryonic stem cell
15	chr4:69521200-69522800	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr4:69521200-69522800	Enhancers	Fetal Intestine Large	intestine
17	chr4:69521400-69522200	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr4:69521400-69522800	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr4:69521600-69522000	Enhancers	Rectal Mucosa Donor 29	rectum
20	chr4:69521600-69522600	Enhancers	H1 Cell Line	embryonic stem cell
21	chr4:69521600-69522800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr4:69521800-69522000	Genic enhancers	Liver	Liver
23	chr4:69521800-69522000	Enhancers	Fetal Intestine Small	intestine
24	chr4:69521800-69522000	Flanking Active TSS	A549	lung
25	chr4:69521800-69522000	Flanking Active TSS	HepG2	liver
26	chr4:69521800-69522200	Enhancers	Pancreatic Islets	Pancreatic Islet
27	chr4:69521800-69522400	Enhancers	Duodenum Mucosa	Duodenum
28	chr4:69521800-69522600	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr4:69521800-69522800	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr4:69521800-69523000	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr4:69522000-69522200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
32	chr4:69522000-69522400	Active TSS	A549	lung
33	chr4:69522000-69522400	Active TSS	GM12878-XiMat	blood
34	chr4:69522000-69522600	Active TSS	HepG2	liver
35	chr4:69522000-69523200	Weak transcription	Fetal Intestine Small	intestine
36	chr4:69522000-69525400	Enhancers	Liver	Liver
37	chr4:69522200-69522600	Active TSS	Rectal Mucosa Donor 29	rectum
38	chr4:69522200-69527400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
39	chr4:69522400-69522600	Flanking Active TSS	A549	lung
40	chr4:69522400-69522600	Flanking Active TSS	GM12878-XiMat	blood
41	chr4:69522400-69523000	Weak transcription	Duodenum Mucosa	Duodenum
42	chr4:69522600-69523000	Flanking Active TSS	HepG2	liver
43	chr4:69522600-69523200	Weak transcription	Stomach Mucosa	stomach
44	chr4:69522600-69523600	Weak transcription	Rectal Mucosa Donor 31	rectum
45	chr4:69522600-69523600	Enhancers	A549	lung
46	chr4:69522600-69523600	Enhancers	GM12878-XiMat	blood
47	chr4:69522800-69523000	Enhancers	Pancreas	Pancrea
48	chr4:69522800-69523200	Weak transcription	Fetal Intestine Large	intestine
49	chr4:69522800-69524400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr4:69522800-69526600	Weak transcription	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links